Industry Symposium: Identifying the right patients for chemotherapy in ER+ HER2- breast cancer
Supported by Genomic Health

Friday, September 6, 2019
Hall B

  Treatment decision-making for young patients in light of new evidence from TAILORx
Tiffany Traina, USA
Should all women with breast cancer and positive lymph nodes receive chemotherapy?
Christy A. Russell, USA